Ubs Group Ag Atri Cure, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Atri Cure, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 116,156 shares of ATRC stock, worth $4.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,156

Previous 103,027 12.74%

Holding current value

$4.07 Million

Previous $3.32 Million 14.54%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$29.07 - $34.94 $381,660 - $458,727	13,129 Added 12.74%	116,156 $3.81 Million
Q1 2025 May 13, 2025	SELL	$30.4 - $42.4 $1.25 Million - $1.74 Million	-41,153 Reduced 28.54%	103,027 $3.32 Million
Q4 2024 Feb 14, 2025	BUY	$27.02 - $38.2 $2.69 Million - $3.81 Million	99,635 Added 223.67%	144,180 $4.41 Million
Q3 2024 Nov 14, 2024	SELL	$20.34 - $29.5 $748,593 - $1.09 Million	-36,804 Reduced 45.24%	44,545 $1.25 Million
Q2 2024 Aug 13, 2024	BUY	$19.86 - $29.09 $183,824 - $269,257	9,256 Added 12.84%	81,349 $1.85 Million
Q1 2024 May 13, 2024	BUY	$28.21 - $37.78 $156,057 - $208,998	5,532 Added 8.31%	72,093 $2.19 Million
Q4 2023 Feb 09, 2024	BUY	$32.99 - $43.25 $1.13 Million - $1.49 Million	34,367 Added 106.75%	66,561 $2.38 Million
Q3 2023 Nov 09, 2023	SELL	$41.12 - $57.73 $46,136 - $64,773	-1,122 Reduced 3.37%	32,194 $1.41 Million
Q2 2023 Aug 11, 2023	BUY	$40.44 - $49.6 $454,383 - $557,305	11,236 Added 50.89%	33,316 $1.64 Million
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $338,648 - $445,804	9,441 Added 74.7%	22,080 $915,000
Q4 2022 Feb 08, 2023	BUY	$33.48 - $47.45 $226,190 - $320,572	6,756 Added 114.84%	12,639 $560,000
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $104,613 - $143,915	2,735 Added 86.88%	5,883 $230,000
Q2 2022 Aug 10, 2022	BUY	$35.1 - $66.01 $60,793 - $114,329	1,732 Added 122.32%	3,148 $129,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $358,420 - $445,544	-6,241 Reduced 81.51%	1,416 $93,000
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $376,469 - $517,437	5,938 Added 345.43%	7,657 $532,000
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $213,936 - $260,812	-3,088 Reduced 64.24%	1,719 $120,000
Q2 2021 Aug 13, 2021	BUY	$64.13 - $80.18 $56,690 - $70,879	884 Added 22.53%	4,807 $382,000
Q1 2021 May 12, 2021	SELL	$53.79 - $66.98 $128,504 - $160,015	-2,389 Reduced 37.85%	3,923 $257,000
Q4 2020 Feb 11, 2021	BUY	$34.56 - $57.55 $218,142 - $363,255	6,312 New	6,312 $351,000
Q3 2020 Nov 12, 2020	SELL	$38.36 - $46.91 $5,523 - $6,755	-144 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$31.78 - $51.19 $2,192 - $3,532	-69 Reduced 32.39%	144 $6,000
Q1 2020 May 01, 2020	SELL	$24.49 - $43.84 $24,538 - $43,927	-1,002 Reduced 82.47%	213 $7,000
Q4 2019 Feb 14, 2020	BUY	$24.06 - $32.51 $12,511 - $16,905	520 Added 74.82%	1,215 $40,000
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $141,645 - $193,461	-5,949 Reduced 89.54%	695 $17,000
Q2 2019 Aug 14, 2019	BUY	$26.85 - $30.74 $172,162 - $197,104	6,412 Added 2763.79%	6,644 $199,000
Q1 2019 May 14, 2019	SELL	$26.38 - $33.34 $492,303 - $622,191	-18,662 Reduced 98.77%	232 $6,000
Q4 2018 Feb 14, 2019	BUY	$26.66 - $34.85 $239,060 - $312,499	8,967 Added 90.33%	18,894 $578,000
Q3 2018 Nov 14, 2018	BUY	$27.62 - $35.58 $146,413 - $188,609	5,301 Added 114.59%	9,927 $348,000
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $63,056 - $97,168	3,209 Added 226.46%	4,626 $125,000
Q1 2018 May 15, 2018	SELL	$15.05 - $21.03 $6,486 - $9,063	-431 Reduced 23.32%	1,417 $29,000
Q4 2017 Feb 14, 2018	SELL	$17.69 - $23.44 $2,211 - $2,930	-125 Reduced 6.34%	1,848 $34,000
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $2,740 - $3,319	137 Added 7.46%	1,973 $44,000
Q2 2017 Aug 14, 2017	BUY	N/A	103 Added 5.94%	1,836 $45,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,733	1,733 $33,000

Others Institutions Holding ATRC

# of Institutions

220

Shares Held

51.8M

Call Options Held

33.5K

Put Options Held

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.63B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account